Amyotrophic lateral sclerosis

Recent articles

Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read

Expanding set of viral tools targets almost any brain cell type

Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.

By Holly Barker
19 November 2024 | 2 min watch
Abstract illustration of antibodies scattered against a peach-colored background.

We found a major flaw in a scientific reagent used in thousands of neuroscience experiments — and we’re trying to fix it.

As part of that ambition, we launched a public-private partnership to systematically evaluate antibodies used to study neurological disease, and we plan to make all the data freely available.

By Mona AlQazzaz, Aled Edwards
5 February 2024 | 6 min read

Explore more from The Transmitter

Susumu Tonegawa.

In memoriam: Susumu Tonegawa, ‘intellectual giant’

He won the Nobel Prize for his work on immunology and then went on to define the field of learning and memory.

By Claudia López Lloreda
17 July 2026 | 6 min read
Research image of mouse and human Purkinje cells.

Purkinje cells evolved to have increasingly complex architecture

An increasing proportion of the cerebellar neurons acquired multiple primary dendrites in humans and other apes, according to a comparison of 11 primate species.

By Siddhant Pusdekar
16 July 2026 | 5 min read